TME-SW
01698
XIAOMI-W
01810
BIDU-SW
09888
TENCENT
00700
JD-SW
09618
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 2.29%24.72B | 2.56%16.24B | 6.87%7.08B | 10.79%33.76B | 10.79%24.16B | 10.02%15.83B | 1.49%6.63B | -6.14%30.47B | -2.86%21.81B | -2.41%14.39B |
Operating income | 2.29%24.72B | 2.56%16.24B | 6.87%7.08B | 10.79%33.76B | 10.79%24.16B | 10.02%15.83B | 1.49%6.63B | -6.14%30.47B | -2.86%21.81B | -2.41%14.39B |
Operating expenses | -5.46%-18.78B | -3.56%-12.4B | -4.65%-5.53B | -10.05%-24.74B | -12.53%-17.81B | -15.58%-11.97B | -9.91%-5.29B | -5.09%-22.48B | -7.01%-15.83B | -6.79%-10.36B |
Gross profit | -6.59%5.94B | -0.51%3.84B | 15.61%1.55B | 12.86%9.02B | 6.21%6.36B | -4.27%3.86B | -22.04%1.34B | -27.85%7.99B | -21.91%5.99B | -20.08%4.03B |
Selling expenses | -7.82%-1.2B | -13.90%-787.87M | -6.49%-396.56M | -10.72%-1.52B | -0.97%-1.11B | 2.46%-691.7M | -10.44%-372.4M | -3.05%-1.37B | -2.27%-1.1B | -7.81%-709.13M |
Administrative expenses | -5.16%-1.36B | -13.23%-908.11M | -15.87%-459.96M | -14.96%-1.82B | -13.38%-1.3B | -10.82%-802.03M | -12.71%-396.97M | 3.19%-1.58B | -0.04%-1.14B | -6.77%-723.76M |
Research and development expenses | 29.66%-116.92M | -21.62%-70.95M | -191.83%-33.98M | -285.22%-301.1M | -181.31%-166.21M | -27.68%-58.34M | -49.22%-11.65M | -9.47%-78.16M | -102.78%-59.08M | -98.66%-45.69M |
Profit from asset sales | 186.88%19.99M | 16.07%6.16M | 207.70%679.43K | 6,055.61%426.53M | 341.81%6.97M | 525.43%5.31M | 27.29%-630.85K | -141.53%-7.16M | -63.38%-2.88M | 63.05%-1.25M |
Revaluation surplus | 134.61%12.82M | 116.17%6.23M | 102.10%842.79K | -291.91%-36.44M | -279.12%-37.04M | -333.94%-38.52M | -257.52%-40.06M | 522.41%18.99M | 194.08%20.68M | 227.54%16.47M |
-Changes in the fair value of other assets | 134.61%12.82M | 116.17%6.23M | 102.10%842.79K | -291.91%-36.44M | -279.12%-37.04M | -333.94%-38.52M | -257.52%-40.06M | 522.41%18.99M | 194.08%20.68M | 227.54%16.47M |
Impairment and provision | 25.34%-39.35M | 35.28%-38.4M | 123.12%2.26M | -52.05%-205.87M | 16.02%-52.71M | -10.50%-59.34M | -2,275.39%-9.75M | -115.73%-135.39M | -31.84%-62.76M | -45.17%-53.7M |
-Other impairment is provision | 25.34%-39.35M | 35.28%-38.4M | 123.12%2.26M | -52.05%-205.87M | 16.02%-52.71M | -10.50%-59.34M | -2,275.39%-9.75M | -115.73%-135.39M | -31.84%-62.76M | -45.17%-53.7M |
Special items of operating profit | -17.79%146.99M | -23.02%87.06M | -45.65%38.23M | -0.04%234.36M | -4.23%178.79M | -5.21%113.09M | 84.51%70.35M | -0.21%234.46M | 5.19%186.68M | -15.30%119.3M |
Operating profit | -16.35%2.82B | -12.28%1.76B | 21.29%537.63M | 12.70%5.05B | -1.20%3.37B | -15.26%2.01B | -53.70%443.25M | -41.15%4.48B | -32.91%3.41B | -32.31%2.37B |
Financing cost | -53.24%-706.32M | -63.09%-399.95M | -165.51%-182.06M | -52.35%-698.52M | -45.08%-460.93M | -48.78%-245.24M | -19.05%-68.57M | -169.29%-458.49M | -166.68%-317.7M | -60.12%-164.83M |
Special items of earning before tax | 26.32%-22.33M | 27.28%-16.13M | 70.64%-3.41M | 26.77%-25.25M | -15.14%-30.31M | 38.13%-22.17M | 28.21%-11.63M | 51.68%-34.48M | -0.17%-26.32M | -115.72%-35.84M |
Earning before tax | -27.38%2.09B | -22.72%1.34B | -3.00%352.15M | 8.48%4.33B | -6.14%2.88B | -19.75%1.74B | -58.91%363.04M | -45.91%3.99B | -37.90%3.07B | -35.86%2.17B |
Tax | 22.13%-510.69M | 17.18%-321.6M | 25.09%-60.17M | -14.89%-1.11B | 2.31%-655.81M | 19.63%-388.32M | 56.00%-80.32M | 38.49%-964.53M | 35.79%-671.29M | 32.07%-483.16M |
After-tax profit from continuing operations | -28.93%1.58B | -24.32%1.02B | 3.28%291.98M | 6.43%3.22B | -7.21%2.22B | -19.78%1.35B | -59.66%282.72M | -47.91%3.02B | -38.47%2.4B | -36.87%1.68B |
Earning after tax | -28.93%1.58B | -24.32%1.02B | 3.28%291.98M | 6.43%3.22B | -7.21%2.22B | -19.78%1.35B | -59.66%282.72M | -47.91%3.02B | -38.47%2.4B | -36.87%1.68B |
Minority profit | 26.49%441.78M | 84.98%291.13M | 229.61%114.52M | 40.44%455.98M | 103.33%349.26M | 63.85%157.38M | 19.20%34.74M | -26.44%324.69M | -48.12%171.77M | -57.75%96.05M |
Profit attributable to shareholders | -39.26%1.14B | -38.74%730.55M | -28.43%177.47M | 2.34%2.76B | -15.75%1.87B | -24.85%1.19B | -63.09%247.98M | -49.68%2.7B | -37.57%2.22B | -34.92%1.59B |
Basic earnings per share | -38.89%0.55 | -39.66%0.35 | -25.00%0.09 | 2.31%1.33 | -15.89%0.9 | -24.68%0.58 | -62.50%0.12 | -49.61%1.3 | -37.79%1.07 | -34.75%0.77 |
Diluted earnings per share | -38.89%0.55 | -38.60%0.35 | -33.33%0.08 | 3.13%1.32 | -15.89%0.9 | -25.97%0.57 | -62.50%0.12 | -50.39%1.28 | -37.79%1.07 | -34.75%0.77 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Unlock the Full List